1977
DOI: 10.1271/bbb1961.41.573
|View full text |Cite
|
Sign up to set email alerts
|

Studies on new antimetabolite produced by microorganism. III. Structure of plumbemycin A and B, antagonists of L-threonine from Streptomyces plumbeus.

Abstract: The structure of plumbemycin A and B, new antimetabolites from Streptomyces plumbeus , which are antagonist of L-threonine, were assigned to be L-alanyl-L-aspartyl-D-2-amino-5phosphono-3-cis-pentenoic acid and L-alanyl-L-asparaginyl-D-2-amino-5-phosphono-3-cispentenoic acid, respectively.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

1995
1995
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 26 publications
(5 citation statements)
references
References 0 publications
0
5
0
Order By: Relevance
“…The following years brought the discovery of a family of antibiotics called rhizocticins (compounds 33-36) [80,81], plumbemycins (compounds 37 and 38) [81][82][83], and phosacetamycin (compound 39) [84], first isolated as secondary metabolites of Bacillus subtilis on the basis of their antifungal activity and were later found as products of Streptomyces plumbeus. They form a library of di-and tripeptides containing C-terminal (Z)-L-2-amino-5-phosphono-3-pentenoic acid, a mimetic of phosphonothreonine, which is the substrate for threonine synthetase.…”
Section: Phosphonopeptide Antibioticsmentioning
confidence: 99%
“…The following years brought the discovery of a family of antibiotics called rhizocticins (compounds 33-36) [80,81], plumbemycins (compounds 37 and 38) [81][82][83], and phosacetamycin (compound 39) [84], first isolated as secondary metabolites of Bacillus subtilis on the basis of their antifungal activity and were later found as products of Streptomyces plumbeus. They form a library of di-and tripeptides containing C-terminal (Z)-L-2-amino-5-phosphono-3-pentenoic acid, a mimetic of phosphonothreonine, which is the substrate for threonine synthetase.…”
Section: Phosphonopeptide Antibioticsmentioning
confidence: 99%
“…As mentioned for PTT, the peptidic phosphonate antibiotics promote uptake by the target organism(s). Upon translocation, these peptides are hydrolyzed to release the active phosphonate-containing amino acids (129-133). Hydrolysis of the C -terminal peptide linkage of dehydrophos would result in an enamine that is expected to hydrolyze to methyl acetylphosphonate, which is a structural analog of pyruvate and could inhibit pyruvate utilizing enzymes.…”
Section: Dehydrophosmentioning
confidence: 99%
“…A direct P-CH 2 bond was evidenced by triplet splitting ( J =21.2 Hz) in the 1 H-coupled 31 P NMR spectrum and by the large coupling constant of J =128.3 Hz in the 13 C NMR spectrum for a CH 2 signal at 28.5 ppm. The structure of phosacetamycin was found to be analogous to 2-amino-5-phosphono-3-pentenoic acid (APPA), a constituent of the rhizocticins (rhizocticin A, Gly-APPA; rhizocticin B, Val-Gly-APPA; rhizocticin C, Ile-Gly-APPA; rhizocticin D, Leu-Gly-APPA) (21) and plumbemycins (plumbemycin A, Ala-Asp-APPA; plumbemycin B Ala-Asn-APPA) (22), by 1 H- 1 H COSY correlations of H-1 with H-2, H-3 with H-2 and H-4, 1 H- 1 H TOCSY correlations of H-1, H-2, H-3, and H-4, and 1 H- 13 C HMBC correlations of H-4 with C-5. APPA and phosacetamycin differ in that phosacetamycin possesses an acetamide group, which has additional signals corresponding to C-1′ (δc 173.1) and C-2′ (δc 21.8) and 1 H- 13 C HMBC correlations of C-1′ with H-4 and H-2′.…”
Section: Resultsmentioning
confidence: 99%